Travere Therapeutics, Inc. (NASDAQ:TVTX) Receives $31.79 Consensus Target Price from Analysts
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the fifteen analysts that are presently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average 1 year price target […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the fifteen analysts that are presently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average 1 year price target […]
